This journal focuses on the economic and policy aspects of healthcare, particularly concerning market access, health technology assessment (HTA), and the cost-effectiveness of medical interventions. It examines how reimbursement decisions, real-world evidence, and value-based pricing influence patient access to treatments, especially for innovative and high-cost drugs. The journal also addresses broader societal impacts of healthcare technologies and policies, including issues of equity and resource allocation.
Multidisciplinary Digital Publishing Institute (MDPI)
✅
Does the journal have a website?
✓ Linked
✅
Is the ISSN verified?
2001-6689
✅
Indexed in a trusted database?
Scopus, DOAJ
✅
Peer review process documented?
Double-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
✅
Not on predatory/blacklists?
✓ Clean
✅
Long-term digital preservation?
Swiss National Library, PMC, CLOCKSS
✅
Plagiarism detection in place?
Yes
✅
Listed in DOAJ (verified OA)?
DOAJ verified
✅
Primary language documented?
English
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Health InformaticsQ2
Health PolicyQ2
Subject Classification
Scopus Categories
Health InformaticsHealth Policy
Research Topics (OpenAlex)
Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic and Financial Impacts of CancerBiomedical Ethics and RegulationHealthcare Policy and ManagementHealthcare cost, quality, practicesPharmaceutical studies and practicesVaccine Coverage and HesitancyPharmaceutical industry and healthcareBiosimilars and Bioanalytical Methods